Exposure-response modeling of cabozantinib in patients with renal cell carcinoma : Implications for patient care - Castellano, Daniel (Hospital Universitario 12 de Octubre (Madrid)) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Benzaghou, Fawzi (Ipsen Pharma) ; Taguieva, Naila (Ipsen Pharma) ; Nguyen, Linh (Exelixis. Inc.) ; Clary, Douglas O. (Exelixis. Inc.) ; Jonasch, Eric W. (The University of Texas MD Anderson Cancer Center) ; Universitat Autònoma de Barcelona
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.